Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8458)
All Articles published online
|
Publishing Process of This Article
|
Jul 18, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li L, Yeo W. Value of quality of life analysis in liver cancer: A clinician’s perspective. World J Hepatol 2017; 9(20): 867-883 [PMID: 28804570 DOI: 10.4254/wjh.v9.i20.867] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i20/867.htm |
| Number | Citing Articles |
| 1 |
Thoin F. Begum, Vidya S Patil, Lin Zhu, Ming-Chin Yeh, Evelyn González, Marilyn A Fraser, Wenyue Lu, Steven Zhu, Nathaly Rubio-Torio, Grace X. Ma, Yin Tan. Assessing Physicians’ Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City. Journal of Community Health 2024; 49(4): 588 doi: 10.1007/s10900-023-01316-3
|
| 2 |
Maryam Hafizi, Somayeh Kalanaky, Hassan Moaiery, Maryam Khayamzadeh, Sajad Noorian, Vahid Kaveh, Hossein Foudazi, Behrooz Gharib, Arash Jenabian, Mohsen Razavi, Saeid Salimi, Saideh Fakharzadeh, Afshin Zarghi, Mohammad Hassan Nazaran, Mohammad Esmaeil Akbari. An Investigation on the Effect of BCc1 Nanomedicine on Gastric Cancer Patients Using EORTC QLQ-STO30 Questionnaire. International Journal of Cancer Management 2019; 12(11) doi: 10.5812/ijcm.94190
|
| 3 |
Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, Yoshinori Iwata, Yoshiyuki Sakai, Kyohei Kishino, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kunihiro Hasegawa, Noriko Ishii, Yukihisa Yuri, Takashi Nishimura, Hiroko Iijima, Shuhei Nishiguchi. Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength. Journal of Clinical Medicine 2018; 7(12): 553 doi: 10.3390/jcm7120553
|
| 4 |
Nan-Yan Chen, Kang-Hua Chen, Yi-Wen Wang, Hsiu-Hsin Tsai, Wei-Chen Lee, Li-Chueh Weng. The impact of symptom distress on health-related quality of life in liver cancer patients receiving arterial chemoembolization: the mediating role of hope. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02529-x
|
| 5 |
Masako Shomura, Haruka Okabe, Maya Sakakibara, Emi Sato, Koichi Shiraishi, Yoshitaka Arase, Kota Tsuruya, Yusuke Mishima, Shunji Hirose, Tatehiro Kagawa. Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma. Cancers 2024; 16(21): 3610 doi: 10.3390/cancers16213610
|
| 6 |
Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, Yoshinori Iwata, Yoshiyuki Sakai, Kyohei Kishino, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kunihiro Hasegawa, Noriko Ishii, Yukihisa Yuri, Takashi Nishimura, Hiroko Iijima, Shuhei Nishiguchi. Serum zinc concentration and quality of life in chronic liver diseases. Medicine 2020; 99(1): e18632 doi: 10.1097/MD.0000000000018632
|
| 7 |
Manisha Verma, James M. Paik, Issah Younossi, Daisong Tan, Hala Abdelaal, Zobair M. Younossi. The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life. Cancer Medicine 2021; 10(18): 6273 doi: 10.1002/cam4.4166
|
| 8 |
Marina Serper, Neehar D. Parikh, Grace Thiele, Nadia Ovchinsky, Shivang Mehta, Alexander Kuo, Chanda Ho, Fasiha Kanwal, Michael Volk, Sumeet K. Asrani, Marwan S. Ghabril, John R. Lake, Raphael B. Merriman, Timothy R. Morgan, Elliot B. Tapper. Patient‐reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology 2022; 76(1): 251 doi: 10.1002/hep.32313
|
| 9 |
Fabiana Coelho Couto Rocha CORRÊA, Pedro Augusto de Carvalho MIRA, Fábio Heleno de Lima PACE, Mateus Camaroti LATERZA, Patricia Fernandes TREVIZAN, Daniel Godoy MARTINEZ. REDUCED PERIPHERAL AND INSPIRATORY MUSCLE ENDURANCE IN PATIENTS WITH LIVER CIRRHOSIS: A CROSS-SECTIONAL STUDY. Arquivos de Gastroenterologia 2021; 58(3): 308 doi: 10.1590/s0004-2803.202100000-53
|
| 10 |
Sarah Mittenentzwei, Sophie Mlitzke, Darija Grisanova, Kai Lawonn, Bernhard Preim, Monique Meuschke. Visually communicating pathological changes: A case study on the effectiveness of phong versus outline shading. Computers & Graphics 2024; 123: 104023 doi: 10.1016/j.cag.2024.104023
|
| 11 |
Leung Li, Stephen L. Chan, Frankie Mo, Edwin P. Hui, Jane Koh, Allen KC Chan, Nelson LS Tang, Cheuk M. Chu, Joyce Hui, Kit F. Lee, Simon Yu, Winnie Yeo. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients. Quality of Life Research 2019; 28(9): 2597 doi: 10.1007/s11136-019-02190-0
|
| 12 |
Yang Deng, Jian Zhu, Ziyi Liu, Maosheng Huang, David W. Chang, Jian Gu. Elevated systemic inflammatory responses, factors associated with physical and mental quality of life, and prognosis of hepatocellular carcinoma. Aging 2020; 12(5): 4357 doi: 10.18632/aging.102889
|
| 13 |
Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, Adithya Suresh, Kaiser Xuan Ming Koh, Wen Hui Lim, Jingxuan Quek, Ansel Tang, Caitlyn Tan, Benjamin Nah, Eunice Tan, Taisei Keitoku, Mark D. Muthiah, Nicholas Syn, Cheng Han Ng, Beom Kyung Kim, Nobuharu Tamaki, Cyrus Su Hui Ho, Rohit Loomba, Daniel Q. Huang. Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis. Clinical and Molecular Hepatology 2022; 28(4): 864 doi: 10.3350/cmh.2022.0136
|
| 14 |
R. Smit, H. K. Luckhoff, L. Phahladira, S. Du Plessis, R. Emsley, L. Asmal. Relapse in schizophrenia: The role of factors other than non‐adherence to treatment. Early Intervention in Psychiatry 2024; 18(9): 710 doi: 10.1111/eip.13510
|
| 15 |
Yakup Ülger, Anıl Delik. Prognostic Value of International Normalized Ratio-to-Albumin Ratio and Ferritin Level in Chronic Liver Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2022; 53(4): 1028 doi: 10.1007/s12029-021-00738-3
|
| 16 |
Brenda L. Den Oudsten, Suzanne M. Skevington. Handbook of Quality of Life in Cancer. 2022; : 13 doi: 10.1007/978-3-030-84702-9_3
|
| 17 |
Danbee Kang, Sungkeun Shim, Juhee Cho, Hyo Keun Lim. Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018. Korean Journal of Radiology 2020; 21(6): 633 doi: 10.3348/kjr.2019.0808
|
| 18 |
Hiroki Nishikawa, Kazunori Yoh, Hirayuki Enomoto, Yoshinori Iwata, Yoshiyuki Sakai, Kyohei Kishino, Yoshihiro Shimono, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kunihiro Hasegawa, Takashi Koriyama, Yukihisa Yuri, Takashi Nishimura, Shuhei Nishiguchi, Hiroko Iijima. Health-Related Quality of Life and Frailty in Chronic Liver Diseases. Life 2020; 10(5): 76 doi: 10.3390/life10050076
|
| 19 |
Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss, Jan Pfeiffenberger. Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2019; 145(11): 2761 doi: 10.1007/s00432-019-03005-y
|
| 20 |
Lei Zhang, Xuan Zhang, Zhaokun Cui, Lijuan Zhou, Kai Qu, Nannan Wang. Effects of high-quality nursing care on psychological outcomes and quality of life in patients with hepatocellular carcinoma. Medicine 2020; 99(35): e21855 doi: 10.1097/MD.0000000000021855
|
| 21 |
Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Minoru Nagayama, Ichiro Takemasa, Toshio Ohyanagi, Thomas T Hui, Toru Mizuguchi. Health-related quality of life in patients that have undergone liver resection: A systematic review and meta-analysis. World Journal of Meta-Analysis 2021; 9(1): 88-100 doi: 10.13105/wjma.v9.i1.88
|
| 22 |
Viktor Andersson, Richard Sawatzky, Joakim Öhlén. Relating person‐centredness to quality‐of‐life assessments and patient‐reported outcomes in healthcare: A critical theoretical discussion. Nursing Philosophy 2022; 23(3) doi: 10.1111/nup.12391
|
| 23 |
Jie Shi, Juxian Sun, Chang Liu, Zongtao Chai, Nanya Wang, Hui Zhang, Shuqun Cheng. All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-019-3349-9
|
| 24 |
Elizabeth Palmer Kelly, J. Madison Hyer, Anghela Z. Paredes, Diamantis Tsilimigras, Bonnie Meyer, Hanci Newberry, Timothy M. Pawlik. Provision of supportive spiritual care for hepatopancreatic cancer patients: an unmet need?. HPB 2021; 23(9): 1400 doi: 10.1016/j.hpb.2021.02.001
|
| 25 |
Kehua Zhou, Christos Fountzilas. Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma. Cancers 2019; 11(6): 861 doi: 10.3390/cancers11060861
|
| 26 |
Leung Li, Frankie Mo, Edwin P. Hui, Stephen L. Chan, Jane Koh, Nelson L. S. Tang, Simon C. H. Yu, Winnie Yeo. The association of liver function and quality of life of patients with liver cancer. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0984-2
|
| 27 |
Arndt Vogel, Shukui Qin, Masatoshi Kudo, Yun Su, Stacie Hudgens, Tatsuya Yamashita, Jung-Hwan Yoon, Laetitia Fartoux, Krzysztof Simon, Carlos López, Max Sung, Kalgi Mody, Tatsuroh Ohtsuka, Toshiyuki Tamai, Lee Bennett, Genevieve Meier, Valery Breder. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. The Lancet Gastroenterology & Hepatology 2021; 6(8): 649 doi: 10.1016/S2468-1253(21)00110-2
|
| 28 |
Lu Wu, Bin Sun, Xuejing Lin, Chunying Liu, Haihua Qian, Lei Chen, Yefa Yang, Feng Shen, Changqing Su. I131 reinforces antitumor activity of metuximab by reversing epithelial–mesenchymal transition via VEGFR‐2 signaling in hepatocellular carcinoma. Genes to Cells 2018; 23(1): 35 doi: 10.1111/gtc.12545
|